Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Central-core disease and malignant hyperpyrexia.

× No keyword cloud information.

5 in total

1. A new congenital non-progressive myopathy.

Authors: K R MAGEE; G M SHY
Journal: Brain Date: 1956-12 Impact factor: 13.501

2. Inheritance of malignant hyperpyrexia.

Authors: J O King; M A Denborough; P W Zapf
Journal: Lancet Date: 1972-02-12 Impact factor: 79.321

3. Myopathy and malignant hyperpyrexia.

Authors: M A Denborough; P Ebeling; J O King; P Zapf
Journal: Lancet Date: 1970-05-30 Impact factor: 79.321

4. Multicore disease. A recently recognized congenital myopathy associated with multifocal degeneration of muscle fibers.

Authors: A G Engel; M R Gomez; R V Groover
Journal: Mayo Clin Proc Date: 1971-10 Impact factor: 7.616

5. Procaine in malignant hyperpyrexia.

Authors: R F Moulds; M A Denborough
Journal: Br Med J Date: 1972-12-02

5 in total

28 in total

1. Malignant hyperthermia associated with atypical central core disease.

Authors: S Akazawa; R Shimizu; H Kasuda; S Nakao; T Nakamigawa
Journal: J Anesth Date: 1987-03-01 Impact factor: 2.078

2. Assignment of the gene for central core disease to chromosome 19.

Authors: E A Haan; C J Freemantle; J A McCure; K L Friend; J C Mulley
Journal: Hum Genet Date: 1990-12 Impact factor: 4.132

3. Central core disease. A correlated genetic, histochemical, ultramicroscopic, and biochemical study.

Authors: H Isaacs; J J Heffron; M Badenhorst
Journal: J Neurol Neurosurg Psychiatry Date: 1975-12 Impact factor: 10.154

4. Identification of susceptibility to malignant hyperpyrexia.

Authors: R F Moulds; M A Denborough
Journal: Br Med J Date: 1974-05-04

5. Malignant hyperthermia: an investigation of five patients.

Authors: B A Britt; W Kalow; A Gordon; J G Humphrey; N B Rewcastle
Journal: Can Anaesth Soc J Date: 1973-07

Review 6. Adverse effects of drugs on muscle.

Authors: F L Mastaglia
Journal: Drugs Date: 1982-10 Impact factor: 9.546

7. N-terminal and central segments of the type 1 ryanodine receptor mediate its interaction with FK506-binding proteins.

Authors: Tanya Girgenrath; Mohana Mahalingam; Bengt Svensson; Florentin R Nitu; Razvan L Cornea; James D Fessenden
Journal: J Biol Chem Date: 2013-04-12 Impact factor: 5.157

8. Diagnosis of malignant hyperthermia: a comparison of the in vitro contracture test with the molecular genetic diagnosis in a large pedigree.

Authors: J M Healy; K A Quane; K E Keating; M Lehane; J J Heffron; T V McCarthy
Journal: J Med Genet Date: 1996-01 Impact factor: 6.318

9. Congenital neuromuscular disease with type I fibre hypotrophy, ophthalmoplegia and myofibril degeneration.

Authors: H Sugie; R Hanson; G Rasmussen; M A Verity
Journal: J Neurol Neurosurg Psychiatry Date: 1982-06 Impact factor: 10.154

10. Minicore myopathy.

Authors: F Gullotta; L Pavone; M La Rosa; A Grasso
Journal: Klin Wochenschr Date: 1982-11-02